William Blair acted as the exclusive financial advisor to Corilus N.V. (Corilus) and Rivean Capital (Rivean) in connection with a pending significant strategic investment from PSG Equity (PSG). The transaction was signed on July 3, 2024, and is expected to close in Q4 2024.
About the Companies
Corilus develops and provides cloud-based innovative software solutions for healthcare providers: general practitioners, pharmacists, dentists, midwives, specialists, ophthalmologists, opticians, nurses, physiotherapists, and elderly care homes. The company offers a full suite of products and support services that care providers use to perform their daily jobs. More than 30,000 care providers in Belgium and France use Corilus software every day. The company employs more than 450 staff based in Belgium and France.
Rivean is a leading European private equity investor in mid-market transactions with operations in the Benelux, DACH region, and Italy. The company has assets under management more than €5 billion and has offices in Amsterdam, Brussels, Frankfurt, Milan, and Zug. Since its inception in 1982, Rivean has supported more than 250 companies in realizing their growth ambitions and has a strong track record of supporting and scaling successful high-tech businesses with cross-border growth agendas, including footprint expansions and operational excellence trajectories.
PSG is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities, and build strong teams. Having backed over 140 companies and facilitated over 500 add-on acquisitions, the firm brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams. Founded in 2014, PSG operates out of offices in Boston, Kansas City, London, Madrid, Paris, and Tel-Aviv.
Learn more about our healthcare IT investment banking expertise.